What is she best known for?
The fields of study she is best known for:
Claire L. Harris spends much of her time researching Complement system, Factor H, Immunology, Innate immune system and Alternative complement pathway.
Her Complement system research integrates issues from Proteases, Biochemistry, Binding site and Cell biology.
Her biological study spans a wide range of topics, including Mutation, Molecular biology, Internal medicine and Complement factor B.
Her Immunology study focuses mostly on Inflammation and Complement.
Her research in Inflammation tackles topics such as Disease which are related to areas like Drug development, Systemic inflammation, Immune defence and Genotype.
Her Innate immune system research focuses on Classical complement pathway and how it connects with T cell, Complement receptor and Acquired immune system.
Her most cited work include:
- Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. (371 citations)
- C3 glomerulopathy: consensus report (326 citations)
- Complement, a target for therapy in inflammatory and degenerative diseases. (214 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of investigation include Immunology, Complement system, Factor H, Cell biology and Alternative complement pathway.
Her study in Immunology concentrates on Complement, Inflammation, Complement receptor, Classical complement pathway and Complement membrane attack complex.
Claire L. Harris combines subjects such as Molecular biology, Innate immune system, Disease and Macular degeneration with her study of Complement system.
The study incorporates disciplines such as Drug development, Bioinformatics and Intensive care medicine in addition to Disease.
Her Factor H study combines topics from a wide range of disciplines, such as Complement factor I, Complement factor B and CD46.
As a part of the same scientific study, she usually deals with the Cell biology, concentrating on Decay-accelerating factor and frequently concerns with Complement receptor 1.
She most often published in these fields:
- Immunology (37.06%)
- Complement system (35.03%)
- Factor H (23.35%)
What were the highlights of her more recent work (between 2015-2021)?
- Complement system (35.03%)
- Macular degeneration (12.18%)
- Complement (18.27%)
In recent papers she was focusing on the following fields of study:
Her primary areas of study are Complement system, Macular degeneration, Complement, Disease and Factor H.
She has researched Complement system in several fields, including Clusterin, Endosome and Cell biology.
Claire L. Harris has included themes like Odds ratio, Alternative complement pathway, Lysosome, Fibrinogen and Immunology in her Macular degeneration study.
She interconnects Downregulation and upregulation and Peritoneal dialysis in the investigation of issues within Immunology.
Her work deals with themes such as Drug development and Bioinformatics, which intersect with Disease.
Her Factor H research is classified as research in Genetics.
Between 2015 and 2021, her most popular works were:
- Complement Factor H Inhibits CD47-Mediated Resolution of Inflammation (67 citations)
- Developments in anti-complement therapy; from disease to clinical trial (38 citations)
- Developments in anti-complement therapy; from disease to clinical trial (38 citations)
In her most recent research, the most cited papers focused on:
Claire L. Harris focuses on Disease, Tissue homeostasis, Eculizumab, Complement system and Drug development.
Her Tissue homeostasis research includes elements of Risk analysis, Clinical trial, Complement and Drug discovery.
Claire L. Harris specializes in Complement system, namely Complement factor I.
Her Biomarker research is multidisciplinary, relying on both Inflammation and Immunology.
CD46 is frequently linked to Factor H in her study.
Her study in Factor H is interdisciplinary in nature, drawing from both Complement factor B and C4A.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
